Spindle cell melanocytic lesions: Part II - An approach to intradermal proliferations and horizontally oriented lesions

Journal of Clinical Pathology

Volumn 63, Issue 5, 2010, Pages 391-409

  Sade, Shachar ^a   Al Habeeb, Ayman ^a   Ghazarian, Danny ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLUE NEVUS; CELL DAMAGE; CELL PROLIFERATION; CELL STRUCTURE; HAMARTOMA; HISTOPATHOLOGY; HUMAN; JUVENILE MELANOMA; MELANOCYTOSIS; PARAGANGLIOMA; PRIORITY JOURNAL; REVIEW; SKIN CELL; SPINDLE CELL;

AGED, 80 AND OVER; ALGORITHMS; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HAMARTOMA; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS, BLUE; NEVUS, SPINDLE CELL; SKIN NEOPLASMS; YOUNG ADULT;

EID: 77951660650     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.075440     Document Type: Review

References (106)

1. Elder DE, Xu X. The approach to the patient with a difficult melanocytic lesion. Pathology 2004;36:428-434 (Pubitemid 39273986)
2. Trotter MJ, Bruecks AK. Interpretation of skin biopsies by general pathologists: diagnostic discrepancy rate measured by blinded review. Arch Pathol Lab Med 2003;127:1489-1492
3. Troxel DB. Medicolegal aspects of error in pathology. Arch Pathol Lab Med 2006;130:617-619
4. Troxel DB. An insurer's perspective on error and loss in pathology. Arch Pathol Lab Med 2005;129:1234-1236
5. van Dijk MC, Aben KK, van Hees F, et al. Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions. Histopathology 2008;52:139-146
6. High WA. Malpractice in dermatopathology: principles, risk mitigation, and opportunities for improved care for the histologic diagnosis of melanoma and pigmented lesions. Clin Lab Med 2008;28:261-284
7. Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000;36:387-402. (Pubitemid 30311621)
8. Lodding P, Kindblom LG, Angervall L. Metastases of malignant melanoma simulating soft tissue sarcoma. A clinico-pathological, light- and electron microscopic and immunohistochemical study of 21 cases. Virchows Arch A Pathol Anat Histopathol 1990;417:377-388
9. Levene A. On the histological diagnosis and prognosis of malignant melanoma. J Clin Pathol 1980;33:101-124 (Pubitemid 10174568)
10. Jonjic N, Zamolo G, Stifter S, et al. Cytomorphological variations, proliferation and angiogenesis in the prognosis of cutaneous melanoma. Clin Exp Dermatol 2003;28:310-314 (Pubitemid 36713824)
11. Bolognia J, Jorizzo JL, Rapini RP. Dermatology. 2nd edn. St. Louis, Mo: Mosby/Elsevier, 2008.
12. McKee PH, Calonje E, Granter SR. Pathology of the skin: with clinical correlations. 3rd edn. Edinburgh: Elsevier Mosby, 2005.
13. Murali R, McCarthy SW, Scolyer RA. Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Adv Anat Pathol 2009;16:365-382
14. Mooi WJ, Krausz T, Mooi WJ. Pathology of melanocytic disorders. 2nd edn. London: Hodder Arnold; 2007.
15. Patterson CR, Acland K, Khooshabeh R. Cutaneous malignant melanoma arising in an acquired naevus of Ota. Australas J Dermatol 2009;50:294-296
16. Baroody M, Holds JB. Extensive locoregional malignant melanoma transformation in a patient with oculodermal melanocytosis. Plast Reconstr Surg 2004;113:317-322 (Pubitemid 39202046)
17. Biswas J, Krishnakumar S. Choroidal melanoma in a black patient with oculodermal melanocytosis. Retina 2003;23:126. author reply 126.
18. Fistarol SK, Itin PH. Plaque-type blue nevus of the oral cavity. Dermatology 2005;211:224-233
19. Rhodes AR, Silverman RA, Harrist TJ, et al. Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: the "LAMB" syndrome. J Am Acad Dermatol 1984;10:72-82.
20. Atherton DJ, Pitcher DW, Wells RS, et al. A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome. Br J Dermatol 1980;103:421-429
21. Fitzpatrick TB, Wolff K. Fitzpatrick's dermatology in general medicine. In: Klaus Wolff, ed. 7th/itors. New York: McGraw-Hill, 2008.
22. Barnhill RL. Textbook of dermatopathology. 2nd edn. New York: McGraw-Hill, 2004. Medical Pub. Division.
23. Lever WF, Elder DE. Lever's histopathology of the skin. 10th edn. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2009.
24. Sun J, Morton TH Jr, Gown AM. Antibody HMB-45 identifies the cells of blue nevi. An immunohistochemical study on paraffin sections. Am J Surg Pathol 1990;14:748-751 (Pubitemid 20233014)
25. Granter SR, McKee PH, Calonje E, et al. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called 'malignant blue nevus'. Am J Surg Pathol 2001;25:316-323
26. Barnhill RL, Argenyi Z, Berwick M, et al. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). Am J Surg Pathol 2008;32:36-44.
27. Temple-Camp CR, Saxe N, King H. Benign and malignant cellular blue nevus. A clinicopathological study of 30 cases. Am J Dermatopathol 1988;10:289-296
28. Tran TA, Carlson JA, Basaca PC, et al. Cellular blue nevus with atypia (atypical cellular blue nevus): a clinicopathologic study of nine cases. J Cutan Pathol 1998;25:252-258
29. Avidor I, Kessler E. 'Atypical' blue nevus - a benign variant of cellular blue nevus. Presentation of three cases. Dermatologica 1977;154:39-44.
30. Ferrara G, Argenziano G, Zgavec B, et al. "Compound blue nevus": a reappraisal of "superficial blue nevus with prominent intraepidermal dendritic melanocytes" with emphasis on dermoscopic and histopathologic features. J Am Acad Dermatol 2002;46:85-89
31. Kamino H, Tam ST. Compound blue nevus: a variant of blue nevus with an additional junctional dendritic component. A clinical, histopathologic, and immunohistochemical study of six cases. Arch Dermatol 1990;126:1330-1333
32. Skowron F, Balme B. Large plaque-type blue naevus with subcutaneous cellular nodules. Clin Exp Dermatol 2009;34:e782-84.
33. Zattra E, Salmaso R, Montesco MC, et al. Large plaque type blue nevus with subcutaneous cellular nodules. Eur J Dermatol 2009;19:287-288
34. Busam KJ, Woodruff JM, Erlandson RA, et al. Large plaque-type blue nevus with subcutaneous cellular nodules. Am J Surg Pathol 2000;24:92-99
35. Wen SY. Plaque-type blue nevus. Review and an unusual Case. Acta Derm Venereol 1997;77:458-459
36. Misago N, Nagase K, Toda S, et al. Cellular blue nevus with nevus cells in a sentinel lymph node. Eur J Dermatol 2008;18:586-589
37. Bortolani A, Barisoni D, Scomazzoni G. Benign "metastatic" cellular blue nevus. Ann Plast Surg 1994;33:426-431
38. Gonzalez-Campora R, Diaz-Cano S, Vazquez-Ramirez F, et al. Cellular blue nevus with massive regional lymph node metastases. Dermatol Surg 1996;22:83-87 (Pubitemid 26038740)
39. al-Qattan MM. Re: Facial plaque-type blue nevus and its reconstruction. Ann Plast Surg 1996;36:559.
40. Hsiao CW, Tung TC, Hsiao GH. Facial plaque-type blue nevus and its reconstruction. Ann Plast Surg 1995;35:326-329
41. Seab JA Jr, Graham JH, Helwig EB. Deep penetrating nevus. Am J Surg Pathol 1989;13:39-44.
42. Ridha H, Ahmed S, Theaker JM, et al. Malignant melanoma and deep penetrating naevusedifficulties in diagnosis in children. J Plast Reconstr Aesthet Surg 2007;60:1252-1255 (Pubitemid 47591357)
43. Robson A, Morley-Quante M, Hempel H, et al. Deep penetrating naevus: clinicopathological study of 31 cases with further delineation of histological features allowing distinction from other pigmented benign melanocytic lesions and melanoma. Histopathology 2003;43:529-537 (Pubitemid 38002341)
44. Barnhill RL, Mihm MC Jr, Magro CM. Plexiform spindle cell naevus: a distinctive variant of plexiform melanocytic naevus. Histopathology 1991;18:243-247
45. Cooper PH. Deep penetrating (plexiform spindle cell) nevus. A frequent participant in combined nevus. J Cutan Pathol 1992;19:172-180
46. Mezebish D, Smith K, Williams J, et al. Neurocristic cutaneous hamartoma: a distinctive dermal melanocytosis with an unknown malignant potential. Mod Pathol 1998;11:573-578 (Pubitemid 28280722)
47. Smith KJ, Mezebish D, Williams J, et al. The spectrum of neurocristic cutaneous hamartoma: clinicopathologic and immunohistochemical study of three cases. Ann Diagn Pathol 1998;2:213-223 (Pubitemid 128654498)
48. Denlinger CE, Slingluff CL Jr, Mihm MC Jr, et al. Extensive neurocristic hamartoma with skeletal muscle involvement. J Cutan Pathol 2007;34:634-639 (Pubitemid 47063233)
49. Crowson AN, Magro CH, Clark WH. Pilar neurocristic hamartoma. J Am Acad Dermatol 1996;34:715.
50. Karamitopoulou-Diamantis E, Paredes B, Vajtai I. Cutaneous neurocristic hamartoma with blue naevus-like features and plexiform dermal hyperneury. Histopathology 2006;49:326-328 (Pubitemid 44253630)
51. Pearson JP, Weiss SW, Headington JT. Cutaneous malignant melanotic neurocristic tumors arising in neurocristic hamartomas. A melanocytic tumor morphologically and biologically distinct from common melanoma. Am J Surg Pathol 1996;20:665-677
52. Pathy AL, Helm TN, Elston D, et al. Malignant melanoma arising in a blue nevus with features of pilar neurocristic hamartoma. J Cutan Pathol 1993;20:459-464 (Pubitemid 23332287)
53. Fraitag S, Vignon-Pennamen MD. Spitz tumor and pigmented epithelioid melanocytoma: New nosological frameworks for commonly ill-defined tumors. Ann Dermatol Venereol 2009;136:133-144
54. Quatresooz P, Pierard-Franchimont C, Pierard GE. Highlighting the immunohistochemical profile of melanocytomas: review. Oncol Rep 2008;19:1367-1372
55. Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 2004;28:31-40. (Pubitemid 38031618)
56. Requena L, de la Cruz A, Moreno C, et al. Animal type melanoma: a report of a case with balloon-cell change and sentinel lymph node metastasis. Am J Dermatopathol 2001;23:341-346 (Pubitemid 32729446)
57. Crowson AN, Magro CM, Mihm MC Jr. Malignant melanoma with prominent pigment synthesis: "animal type" melanomaea clinical and histological study of six cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis. Hum Pathol 1999;30:543-550
58. Levene A. Disseminated dermal melanocytosis terminating in melanoma. A human condition resembling equine melanotic disease. Br J Dermatol 1979;101:197-205. (Pubitemid 10134821)
59. Sarma DP, Teruya B, Wang B. Paraganglioma-like dermal melanocytic tumor: a case report. Cases J 2008;1:48.
60. Deyrup AT, Althof P, Zhou M, et al. Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma. Am J Surg Pathol 2004;28:1579-1586 (Pubitemid 39564962)
61. Ferrara G, Brasiello M, Annese P, et al. Desmoplastic nevus: clinicopathologic keynotes. Am J Dermatopathol 2009;31:718-722
62. Nojavan H, Cribier B, Mehregan DR. Desmoplastic Spitz nevus: a histopathological review and comparison with desmoplastic melanoma. Ann Dermatol Venereol 2009;136:689-695
63. Dhouib RS, Sassi S, Jbeli A, et al. Desmoplastic spitz nevus: report of a case and review of the literature. Pathologica 2008;100:181-184
64. Martin JM, Jorda E, Monteagudo C, et al. Desmoplastic giant congenital nevus with progressive depigmentation. J Am Acad Dermatol 2007;56(2 Suppl):S10-4. (Pubitemid 46074269)
65. Mackie RM, Doherty VR. The desmoplastic melanocytic naevus: a distinct histological entity. Histopathology 1992;20:207-211
66. Kerl H, Soyer HP, Cerroni L, et al. Ancient melanocytic nevus. Semin Diagn Pathol 1998;15:210-215
67. Chen JY, Hruby G, Scolyer RA, et al. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer 2008;113:2770-2778
68. de Almeida LS, Requena L, Rutten A, et al. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases. Am J Dermatopathol 2008;30:207-215
69. Quinn MJ, Crotty KA, Thompson JF, et al. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998;83:1128-1135 (Pubitemid 28419065)
70. Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br J Dermatol 2005;152:673-678
71. DiCaudo DJ, McCalmont TH, Wick MR. Selected diagnostic problems in neoplastic dermatopathology. Arch Pathol Lab Med 2007;131:434-439
72. Hilliard NJ, Krahl D, Sellheyer K. p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma. J Cutan Pathol 2009;36:753-759
73. Kucher C, Zhang PJ, Pasha T, et al. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol 2004;26:452-457 (Pubitemid 40082508)
74. Wilsher M, Cheerala B. WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections. Histopathology 2007;51:605-610 (Pubitemid 47572869)
75. Magro CM, Crowson AN, Mihm MC. Unusual variants of malignant melanoma. Mod Pathol 2006;19(Suppl. 2):S41-70.
76. Folpe AL, Cooper K. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors. Arch Pathol Lab Med 2007;131:1517-1524 (Pubitemid 47606717)
77. Chorny JA, Barr RJ. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma. Am J Dermatopathol 2002;24:309-312
78. Kaneishi NK, Cockerell CJ. Histologic differentiation of desmoplastic melanoma from cicatrices. Am J Dermatopathol 1998;20:128-134
79. Robson A, Allen P, Hollowood K. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma. Histopathology 2001;38:135-140 (Pubitemid 32193627)
80. Swetter SM, Ecker PM, Johnson DL, et al. Primary dermal melanoma: a distinct subtype of melanoma. Arch Dermatol 2004;140:99-103.
81. Hida Y, Kubo Y, Miyajima O, et al. Primary dermal melanoma: A case report and molecular characterization. J Dermatol 2009;36:346-352
82. Cassarino DS, Cabral ES, Kartha RV, et al. Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma. Arch Dermatol 2008;144:49-56.
83. Plaza JA, Torres-Cabala C, Evans H, et al. Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum. Am J Dermatopathol. Published Online First: 14 Dec 2009. doi:10.1097/DAD.0b013e3181b34a19.
84. Barnhill RL, Barnhill MA, Berwick M, et al. The histologic spectrum of pigmented spindle cell nevus: a review of 120 cases with emphasis on atypical variants. Hum Pathol 1991;22:52-58
85. Lee HW, Ahn SJ, Lee MW, et al. Pseudomelanoma following laser therapy. J Eur Acad Dermatol Venereol 2006;20:342-344
86. Boer A, Wolter M, Kaufmann R. Pseudomelanoma following laser treatment or laser-treated melanoma? J Dtsch Dermatol Ges 2003;1:47-50.
87. Hwang K, Lee WJ, Lee SI. Pseudomelanoma after laser therapy. Ann Plast Surg 2002;48:562-564
88. Trau H, Orenstein A, Schewach-Miller M, et al. Pseudomelanoma following laser therapy for congenital nevus. J Dermatol Surg Oncol 1986;12:984-986 (Pubitemid 16026572)
89. Grunwald MH, Gat A, Amichai B. Pseudomelanoma after Solcoderm treatment. Melanoma Res 2006;16:459-460
90. Goldenhersh MA, Scheflan M, Zeligovsky A. Recurrent melanocytic nevi after Solcoderm therapy: a new cause of pseudomelanoma. J Am Acad Dermatol 1992;27(6 Pt 1):1012-1013
91. King R, Hayzen BA, Page RN, et al. Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol 2009;22:611-617
92. Harvell JD, Bastian BC, LeBoit PE. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases. Am J Surg Pathol 2002;26:654-661
93. Ferrara G, Giorgio CM, Zalaudek I, et al. Sclerosing nevus with pseudomelanomatous features (nevus with regression-like fibrosis): clinical and dermoscopic features of a recently characterized histopathologic entity. Dermatology 2009;219:202-208
94. Selim MA, Vollmer RT, Herman CM, et al. Melanocytic nevi with nonsurgical trauma: a histopathologic study. Am J Dermatopathol 2007;29:134-136
95. Carlson JA, Mu XC, Slominski A, et al. Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol 2002;138:77-87. (Pubitemid 34056237)
96. El Shabrawi-Caelen L, Soyer HP, Schaeppi H, et al. Genital lentigines and melanocytic nevi with superimposed lichen sclerosus: a diagnostic challenge. J Am Acad Dermatol 2004;50:690-694 (Pubitemid 38580544)
97. Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 1987;116:303-310
98. Rodriguez J, Nonaka D, Kuhn E, et al. Combined high-grade basal cell carcinoma and malignant melanoma of the skin ("malignant basomelanocytic tumor"): report of two cases and review of the literature. Am J Dermatopathol 2005;27:314-318 (Pubitemid 41232484)
99. Ohsie SJ, Sarantopoulos GP, Cochran AJ, et al. Immunohistochemical characteristics of melanoma. J Cutan Pathol 2008;35:433-444
100. Bosbous MW, Dzwierzynski WW, Neuburg M. Lentigo maligna: diagnosis and treatment. Clin Plast Surg 2010;37:35-46.
101. Bosbous MW, Dzwierzynski WW, Neuburg M. Staged excision of lentigo maligna and lentigo maligna melanoma: a 10-year experience. Plast Reconstr Surg 2009;124:1947-1955
102. McKenna JK, Florell SR, Goldman GD, et al. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg 2006;32:493-504.
103. LeBoit PE, Burg G, Weedon D, et al. Pathology & genetics: skin tumours. Lyon, France: IARC Press, 2006.
104. Scolyer RA, Zhuang L, Palmer AA, et al. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma. Pathology 2004;36:419-427 (Pubitemid 39273985)
105. Tannous ZS, Mihm MC Jr, Sober AJ, et al. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol 2005;52:197-203.
106. Xu X, Bellucci KS, Elenitsas R, et al. Cellular nodules in congenital pattern nevi. J Cutan Pathol 2004;31:153-159 (Pubitemid 38130425)